Ignite Creation Date:
2024-05-05 @ 5:17 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00421135
Status:
COMPLETED
Last Update Posted:
2009-09-17
First Post:
2007-01-10
Brief Title:
A Protocol for the Safety and Tolerance of Intravenous Isophosphoramide Mustard IPM in Patients With Advanced Cancer
Sponsor:
Alaunos Therapeutics
Organization:
Alaunos Therapeutics
Organization Data
Organization:
Alaunos Therapeutics
Class:
INDUSTRY
Study ID:
IPM1001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Alaunos Therapeutics
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Jonathan Lewis MD PhD Chief Medical Officer
Old Organization:
ZIOPHARM Oncology Inc